Piper Jaffray downgrades Allscripts (Nasdaq: MDRX) from Buy to Neutral and lowers their price target from $18 to $15, citing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE